Hemophilia Clinical Trials in London
6 recruitingLondon, United Kingdom
Showing 1–6 of 6 trials
Recruiting
Phase 3
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Hemophilia B
CSL Behring20 enrolled10 locationsNCT07080905
Recruiting
Phase 1Phase 2
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Hemophilia B
Regeneron Pharmaceuticals130 enrolled41 locationsNCT06379789
Recruiting
Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Hemophilia AHemophilia B
Pfizer245 enrolled75 locationsNCT05145127
Recruiting
Phase 3
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Hemophilia AHemophilia B
Pfizer100 enrolled66 locationsNCT05611801
Recruiting
Phase 4
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
Hemophilia A
Swedish Orphan Biovitrum250 enrolled27 locationsNCT06940830
Recruiting
Not Applicable
Liver Biopsy In Haemophilia Gene Therapy
Hemophilia A, SevereHemophilia B, Severe
University College, London10 enrolled1 locationNCT04817462